Allovir, Inc. (ALVR) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Allovir, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Allovir, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $5.03 M, a 49.8% decline year-over-year.
  • Allovir, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $35.8 M, a 12.5% decline year-over-year.
  • Allovir, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.8 M, a 1.3% decline from 2022.
  • Allovir, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $41.3 M, a 6.05% decline from 2021.
  • Allovir, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $44 M, a 366% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $35.8 M $5.03 M -$5 M -49.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $40.8 M $9.99 M +$952 K +10.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $39.8 M $10.5 M -$387 K -3.57% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $40.2 M $10.3 M -$663 K -6.05% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $40.9 M $10 M -$438 K -4.19% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $41.3 M $9.04 M -$6.82 M -43% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $48.1 M $10.9 M +$569 K +5.53% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $47.6 M $11 M +$1.23 M +12.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $46.3 M $10.5 M +$2.36 M +29.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $44 M $15.9 M +$11.4 M +258% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-15
Q3 2021 $32.5 M $10.3 M +$6.43 M +166% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $26.1 M $9.73 M +$9.23 M +1877% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $16.9 M $8.1 M +$7.46 M +1154% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $9.43 M $4.43 M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-10
Q3 2020 $3.86 M +$3.26 M +548% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $492 K -$949 K -65.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $646 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $596 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.44 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-09-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.